AJP - Endo Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 276: E19-E24, 1999;
0193-1849/99 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, F.
Right arrow Articles by Permert, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, F.
Right arrow Articles by Permert, J.
Vol. 276, Issue 1, E19-E24, January 1999

Islet amyloid polypeptide tonally inhibits beta -, alpha -, and delta -cell secretion in isolated rat pancreatic islets

Feng Wang1, Thomas E. Adrian3, Gunilla T. Westermark2, Xianzhong Ding3, Thomas Gasslander2, and Johan Permert1

1 Department of Surgery, Karolinska Institute at Huddinge University Hospital, Huddinge 14186; 2 Department of Biomedicine and Surgery, Linköping University Hospital, Linköping 58185, Sweden; and 3 Department of Biomedical Sciences, Creighton University School of Medicine, Omaha, Nebraska 68178

Islet amyloid polypeptide (IAPP, or amylin) is produced in pancreatic beta -cells. The intraislet significance of IAPP is still uncertain. In the present study, paracrine effects of endogenous IAPP and somatostatin were investigated in isolated rat pancreatic islets. The intraislet IAPP activity was inhibited with an IAPP antiserum or a specific antagonist [IAPP-(8---37)]. Somatostatin activity was inhibited by immunoneutralization. Basal insulin and glucagon secretion were not affected by the somatostatin and/or IAPP blockade. Arginine-stimulated insulin and glucagon secretion were dose dependently increased by IAPP antiserum, IAPP-(8---37), and somatostatin antiserum, respectively. Arginine-stimulated somatostatin secretion was dose dependently potentiated by IAPP antiserum. Insulin secretion induced by 16.7 mM glucose was enhanced by IAPP antiserum and IAPP-(8---37), respectively. A combination of somatostatin antiserum with IAPP antiserum or IAPP-(8---37) further enhanced the arginine-stimulated insulin and glucagon secretion compared with effects when the blocking reagents were used individually. These results indicate that endogenously produced IAPP tonally inhibits stimulated insulin, glucagon, and somatostatin secretion. Furthermore, the paracrine effects of IAPP and somatostatin are additive.

amylin; somatostatin; insulin; glucagon


This article has been cited by other articles:


Home page
J EndocrinolHome page
I. Quesada, E. Tuduri, C. Ripoll, and A. Nadal
Physiology of the pancreatic {alpha}-cell and glucagon secretion: role in glucose homeostasis and diabetes
J. Endocrinol., October 1, 2008; 199(1): 5 - 19.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
C.-j. Huang, L. Haataja, T. Gurlo, A. E. Butler, X. Wu, W. C. Soeller, and P. C. Butler
Induction of endoplasmic reticulum stress-induced -cell apoptosis and accumulation of polyubiquitinated proteins by human islet amyloid polypeptide
Am J Physiol Endocrinol Metab, December 1, 2007; 293(6): E1656 - E1662.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
R. A. Silvestre, J. Rodriguez-Gallardo, C. Jodka, D. G. Parkes, R. A. Pittner, A. A. Young, and J. Marco
Selective amylin inhibition of the glucagon response to arginine is extrinsic to the pancreas
Am J Physiol Endocrinol Metab, March 1, 2001; 280(3): E443 - E449.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
C. B. Juhl, N. Porksen, J. Sturis, A. P. Hansen, J. D. Veldhuis, S. Pincus, M. Fineman, and O. Schmitz
High-frequency oscillations in circulating amylin concentrations in healthy humans
Am J Physiol Endocrinol Metab, March 1, 2000; 278(3): E484 - E490.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online